Sudarshan Chemical: Analysts’ targets up to ₹1,700

Price action: late-May softness after a volatile run

Sudarshan Chemical Industries Ltd. was trading at ₹970.75, down ₹8.10 (-0.83%), as of 29 May, 2026 | 09:26. The session’s day range was shown at ₹967.65 to ₹990.00, indicating the stock was moving within a relatively tight band early in the day.

Another price snapshot from May 27, 2026 showed the stock at ₹976.00 (-2.56%), with a stated trading range of ₹1,031.00 and ₹975.25. The same update cited a previous close of ₹1,001.65, highlighting how quickly sentiment and pricing shifted across sessions.

A separate “share price update” also indicated the stock had moved down -0.74% from a previous close of ₹975.00, with the last traded price listed at ₹967.80. While these are point-in-time prints from different sources and timestamps, they collectively place the stock in the high-₹960s to mid-₹970s zone across late May.

Day range, 52-week range, and what the extremes show

The same 29 May data showed a 52-week range of ₹726.40 to ₹1,603.00. Another market snapshot listed the 52-week high at ₹1,603.00 (24-Sep-2025) and the 52-week low at ₹796.15 (03-Mar-2025).

These range prints matter because they frame the stock’s drawdowns and rallies against the last year’s peak. At the top end, ₹1,603 represents the reference point for prior optimism. At the lower end, the range suggests the stock has, at different times, traded materially below current levels.

Some datasets also carried exchange band information, showing an upper band of ₹1,434.90 and a lower band of ₹956.70. With late-May trading around ₹968-₹976, the lower band level is close to the recent traded zone.

BSE market depth: where bids and offers were stacked

A BSE Market Depth snapshot dated 29 May 2026 showed the top bid/ask at ₹972.35 / ₹974.15. The table reported Total buy quantity: 15,651 and Total sell quantity: 6,689 at the time of capture.

The top buy levels included small quantities such as 1 share at ₹972.35 and 5 shares at ₹972.15, while the sell side showed 1 share at ₹974.15 and 4 shares at ₹974.30, among other levels. Market depth is dynamic and can change quickly, but it offers a snapshot of near-term liquidity and where immediate buy and sell interest was visible.

Another depth-like table (separately presented) showed bids around ₹1,186-₹1,187 and asks around ₹1,188.20-₹1,188.60, illustrating that different timestamps or feeds can reflect very different price regimes for the same stock.

Broker calls: targets span ₹780 to ₹1,700

Brokerage views cited in the provided data showed a wide spread in targets and ratings. Anand Rathi was described as bullish and carried a Buy view with a target price of ₹1,700 in research reports dated September 25, 2025 and July 30, 2025.

A separate Anand Rathi table also displayed a target price of ₹1,540 (with the recommendation price shown as “-”), and another entry listed Reco Price ₹1,420.00 with Target Price ₹1,700. These references indicate that the firm’s target framework has been presented in multiple ways across different snapshots.

Other brokerages mentioned included Sharekhan with a Buy and target of ₹1,224 (report dated October 28, 2024), LKP Research with a Hold and target of ₹1,117 (report dated October 11, 2024), and ICICI Securities with a Reduce and target of ₹780 (report dated August 05, 2024).

Elara Capital: Accumulate at ₹1,047, but with EBITDA cuts

A note titled “Accumulate Sudarshan Chemical Ltd For Target ₹1,047 By Elara Capital” pointed to operational and demand-related concerns. The report stated the stock price had fallen 11% in the past three months and underperformed the NSE Small-Cap Index (down 6%).

Elara attributed the underperformance to margin concerns post the Heubach acquisition and weakening of dyes and pigments demand globally. On estimates, the note said Elara decreased EBITDA by 5% for FY26E, 4% for FY27E, and 8% for FY28E, based on revised FY26 guidance for the acquired business (Heubach).

The note added that it rolled over the target price to FY28 estimates and retained Accumulate with a TP of ₹1,047. The target was described as being derived from a DCF valuation, assuming a 4% terminal growth rate and a 10.9% cost of capital.

Technical and event-driven references in the feed

One section in the data referenced a sharp upside move, stating the stock “soared” 7.74% to ₹878.6 on the NSE and formed a “long bullish candle” after a breakout from more than a month of consolidation. The snippet did not provide a specific date for that move, but it indicates that Sudarshan Chemical has seen strong event-driven rallies in the recent past.

Another dataset titled “Share Price Target 2026” showed the stock classified as Chemicals with market cap ₹8,274.51 crore. It also displayed a target price range of ₹1,293.10 to ₹1,700.00, with CMP ₹1,030.00 (-0.67%) as of 20 Nov 2025, 03:30 pm, and a “Bullish” market trend label based on 3 research reports and 6 technical indicators.

What this means for investors tracking the stock

The combined picture from these snippets is that the stock is being evaluated through two competing lenses. One is the upside implied by high brokerage targets such as ₹1,700. The other is near-term caution flagged in reports like Elara’s, where margins and global demand conditions are central to the thesis.

For investors, the key is that the same stock can carry very different targets depending on assumptions and timeframes. Targets in the data range from ₹780 (Reduce) to ₹1,700 (Buy), and the stock itself has been shown trading around ₹968-₹976 in late May 2026, after previously printing much higher levels within the 52-week range.

Key figures snapshot

Brokerage targets mentioned

Conclusion: wide target dispersion, focus stays on margins

Sudarshan Chemical’s late-May trading around ₹968-₹976 sits well below the ₹1,603 52-week high cited in the data, while brokerage targets span from ₹780 on the bearish end to ₹1,700 on the bullish end. Elara’s note highlights the near-term debate around the Heubach acquisition, margin concerns, and global dyes and pigments demand, alongside continued coverage from multiple brokerages.

The next set of market moves will likely continue to be interpreted through those same signposts: how the acquired business performs versus guidance, and whether margins stabilise as the demand backdrop evolves.